MedPath

Healthy Hearts: Leveraging the Diabetes Prevention Program to Decrease Health Disparities in Women of Reproductive Age

Not Applicable
Withdrawn
Conditions
Gestational Weight Gain
Overweight or Obesity
Prediabetic State
Hypertension
Registration Number
NCT05379296
Lead Sponsor
The University of Texas Medical Branch, Galveston
Brief Summary

Nearly half of women have obesity and/or hypertension (HTN). Specific to women, pregnancy creates a vulnerable window for excess gestational weight gain (GWG), exacerbating intergenerational risks for obesity, HTN, type 2 diabetes (T2D), and cardiovascular disease (CVD) across the lifespan. Healthy lifestyles are the first-line recommendations for prevention and treatment of overweight/obesity, HTN, T2D, and CVD. The Diabetes Prevention Program (DPP) is a well-established, Centers for Disease Control and Prevention (CDC)-led public health program focusing on healthy lifestyle changes and is effective at reducing 5-7% of body weight, lowering risks for T2D. Interestingly, research investigating the DPP as a lifestyle intervention for other chronic conditions (i.e., overweight/obesity and HTN) is lacking, demonstrating a missed opportunity. The aim of this study is to determine the initial effects of the first 6-months and after receiving the full 12-months of the virtual DPP compared to the DPP expanded with a CDC-approved HTN prevention component (DPP+) on physical activity, diet, weight, and CVD risk factors in 30 prediabetic women (18-45 years old) with a history of excess GWG, overweight/obesity, and HTN. Participants will be recruited through University of Texas Medical Branch (UTMB) community-based clinics using Epic. The Participants will be randomized into 2 groups (DPP and DPP+) and guided through the 12-month virtual DPP or DPP+ program using UTMB DPP personnel.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • Women with prediabetes and eligible for the DPP, overweight/obesity, HTN (diagnosed or 3 successive high blood pressure readings), and history of excess gestational weight gain during most recent pregnancy
Exclusion Criteria
  • Pregnant and lactating women, participants planning to move out of Galveston County within the next year

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from Baseline Low-density lipoproteins at 12 monthsBaseline, 12-months
Change from Baseline Systolic Blood Pressure at 6 monthsBaseline, 6-months
Change from Baseline High-density lipoproteins at 6 monthsBaseline, 6-months
Change from Baseline Low-density lipoproteins at 6 monthsBaseline, 6-months
Change from Baseline Systolic Blood Pressure at 12 monthsBaseline, 12-months
Change from Baseline Diastolic Blood Pressure at 6 monthsBaseline, 6-months
Change from Baseline Diastolic Blood Pressure at 12 monthsBaseline, 12-months
Change from Baseline Total cholesterol at 6 monthsBaseline, 6-months
Change from Baseline High-density lipoproteins at 12 monthsBaseline, 12-months
Change from Baseline Fasting blood glucose at 6 monthsBaseline, 6-months
Change from Baseline Triglycerides at 6 monthsBaseline, 6-months
Change from Baseline Triglycerides at 12 monthsBaseline, 12-months
Change from Baseline Total cholesterol at 12 monthsBaseline, 12-months
Change from Baseline Hemoglobin a1c at 6 monthsBaseline, 6-months
Change from Baseline Weight at 12 monthsBaseline, 12-months
Change from Baseline Fasting blood glucose at 12 monthsBaseline, 12-months
Change from Baseline Hemoglobin a1c at 12 monthsBaseline, 12-months
Change from Baseline Weight at 6 monthsBaseline, 6-months
Change from Baseline Body mass index at 12 monthsBaseline, 12-months
Change from Baseline Body mass index at 6 monthsBaseline, 6-months
Change from Baseline Serum insulin at 6 monthsBaseline, 6-months
Change from Baseline Serum insulin at 12 monthsBaseline, 12-months
Secondary Outcome Measures
NameTimeMethod
Change from Baseline Total portions of Combined Weekly Fruit and Vegetable Consumption at 12 monthsBaseline, 12-months

Measured using the PreventT2 Diabetes Prevention Program questionnaire

Change from Baseline Total portions of Fried Food Consumption at 6 monthsBaseline, 6-months

Measured using the PreventT2 Diabetes Prevention Program questionnaire

Change from Baseline Subjective Weekly Physical activity at 6 monthsBaseline, 6-months

Stanford Brief Leisure-Time Activity Categorical Item (L-CAT 2.2)

Change from Baseline Total portions of Combined Weekly Fruit and Vegetable Consumption at 6 monthsBaseline, 6-months

Measured using the PreventT2 Diabetes Prevention Program questionnaire

Change from Baseline Objective Total Weekly Physical activity minutes at 6 monthsBaseline, 6-months

Measured using Fitbit Inspire 2

Change from Baseline Visceral adiposity tissue at 6 monthsBaseline, 6-months

Measured using Dual energy X-ray absorptiometry

Change from Baseline C-reactive protein at 12 monthsBaseline, 12-months
Change from Baseline Total portions of Fried Food Consumption at 12 monthsBaseline, 12-months

Measured using the PreventT2 Diabetes Prevention Program questionnaire

Change from Baseline Subjective Weekly Physical activity at 12 monthsBaseline, 12-months

Stanford Brief Leisure-Time Activity Categorical Item (L-CAT 2.2)

Change from Baseline Objective Total Weekly Physical activity minutes at 12 monthsBaseline, 12-months

Measured using Fitbit Inspire 2

Change from Baseline C-reactive protein at 6 monthsBaseline, 6-months
Change from Baseline Visceral adiposity tissue at 12 monthsBaseline, 12-months

Measured using Dual energy X-ray absorptiometry

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.